Drug
Tarperprumig
Tarperprumig: highest development phase Phase 2, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tarperprumig NCT07160608 | Phase 2 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis |
Latest
No recent events.
Follow Tarperprumig on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.